136 filings
Page 2 of 7
CORRESP
sg5qkcz3aeea8735he0d
24 Aug 23
Correspondence with SEC
12:00am
UPLOAD
0lw6503k
24 Aug 23
Letter from SEC
12:00am
S-3
897sfzjik qh
18 Aug 23
Shelf registration
8:41am
RW
885vop3q
18 Aug 23
Registration withdrawal request
8:38am
S-3ASR
zi1rayut uan
17 Aug 23
Automatic shelf registration
4:01pm
8-K
6fbdwe7u
8 Aug 23
Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update
4:01pm
D
x3og e1qxh
7 Aug 23
$212.10 mm in equity / options, sold $212.10 mm, 70 investors
4:44pm
8-K
1ikytf4v5zgtt
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
6vwi0aoht5bso ip
20 Jul 23
Interim TORREY OLE Update and PROSERA Phase 3 Design July 2023
7:50am
8-K
hp0ct8gkn7ui47k2t
9 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:14pm
DEFA14A
qvlj5fg
9 May 23
Additional proxy soliciting materials
4:04pm
8-K
zf6dx 2ywpgv
9 May 23
Gossamer Bio Announces First Quarter 2023 Financial Results and Provides Business Update
4:03pm
ARS
swkbxngi 44ljzzs
28 Apr 23
Annual report to shareholders
4:03pm
DEFA14A
evu4u77l30xw5
28 Apr 23
Additional proxy soliciting materials
4:02pm
PRE 14A
dou aaamynvg35n6
17 Apr 23
Preliminary proxy
4:01pm
8-K
zab7u
3 Apr 23
Other Events
4:01pm